Related Experiment Videos
Bleomycin, ifosfamide, and cisplatin (BIP) in patients with recurrent and advanced cervical cancer
Gynecologic Oncology
|July 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effect of recombinant human tumor-necrosis-factor-alpha and dequalinium chloride on human ovarian-cancer cell-lines in-vitro.
International journal of oncology·2011
Recruitment strategies for cervical cancer prevention study.
Gynecologic oncology·2002
In vitro chemosensitivity testing and mechanisms of drug resistance.
Current oncology reports·2000
Malignant germ cell tumors of the ovary.
Obstetrics and gynecology·2000
Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1999
[Sacituzumab govitecan in a patient with early bone recurrence of triple-negative breast cancer refractory to first-line chemotherapy.]
Recenti progressi in medicina·2026
Quercetin Attenuates Cisplatin-Induced Nephrotoxicity While Enhancing Antitumor Efficacy in Gastric Cancer via Cell Type-Specific Modulation of the ERK1/2 Pathway.
Journal of biochemical and molecular toxicology·2026
Gedatolisib for the treatment of hormone receptor-positive/HER2-negative advanced breast cancer: a European perspective.
Future oncology (London, England)·2026
Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation for the Treatment of Early-Stage Hepatocellular Carcinoma.
Journal of medical imaging and radiation oncology·2026